Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

325 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Expression of integrin αvβ3 in medullary thyroid carcinoma.
de Vries LH, Lodewijk L, Pijnappel EW, van Diest PJ, Schepers A, Bonenkamp HJ, van Engen-van Grunsven IA, Kruijff S, van Hemel BM, Links TP, Nieveen van Dijkum EJ, van Eeden S, van Leeuwaarde RS, Valk GD, de Keizer B, Borel Rinkes IH, Vriens MR. de Vries LH, et al. Among authors: links tp. Future Oncol. 2024;20(27):2015-2022. doi: 10.1080/14796694.2024.2376511. Epub 2024 Aug 5. Future Oncol. 2024. PMID: 39101553 Free PMC article.
Thyroid Lobectomy for Low-Risk 1-4 CM Papillary Thyroid Cancer is not Associated with Increased Recurrence Rates in the Dutch Population with a Restricted Diagnostic Work-Up.
Lin JF, Rodriguez Schaap PM, Metman MJH, Nieveen van Dijkum EJM, Dickhoff C, Links TP, Kruijff S, Engelsman AF. Lin JF, et al. Among authors: links tp. World J Surg. 2023 May;47(5):1211-1218. doi: 10.1007/s00268-022-06813-5. Epub 2022 Oct 27. World J Surg. 2023. PMID: 36303039 Free PMC article.
MET-receptor targeted fluorescent imaging and spectroscopy to detect multifocal papillary thyroid cancer.
Metman MJH, Jonker PKC, Sondorp LHJ, van Hemel BM, Sywak MS, Gill AJ, Jansen L, van Diest PJ, van Ginhoven TM, Löwik CWGM, Nguyen AH, Robinson DJ, van Dam GM, Links TP, Coppes RP, Fehrmann RSN, Kruijff S. Metman MJH, et al. Among authors: links tp. Eur J Nucl Med Mol Imaging. 2024 Jul;51(8):2384-2394. doi: 10.1007/s00259-023-06525-5. Epub 2023 Nov 29. Eur J Nucl Med Mol Imaging. 2024. PMID: 38017325 Free PMC article. Clinical Trial.
Head-to-head comparison of [11C]methionine PET, [11C]choline PET, and 4-dimensional CT as second-line scans for detection of parathyroid adenomas in primary hyperparathyroidism.
Noltes ME, Kruijff S, Appelman APA, Jansen L, Zandee WT, Links TP, van Hemel BM, Schouw HM, Dierckx RAJO, Francken AB, Kelder W, van der Hoorn A, Brouwers AH. Noltes ME, et al. Among authors: links tp. Eur J Nucl Med Mol Imaging. 2024 Mar;51(4):1050-1059. doi: 10.1007/s00259-023-06488-7. Epub 2023 Nov 17. Eur J Nucl Med Mol Imaging. 2024. PMID: 37975887 Free PMC article.
[A rapidly enlarging neck mass].
Lin JF, Links TP, Broekman KE, van Hemel B, Vister J, Verbeek HHG, Brouwers AH, Kruijff S. Lin JF, et al. Among authors: links tp. Ned Tijdschr Geneeskd. 2024 Jun 10;168:D7899. Ned Tijdschr Geneeskd. 2024. PMID: 38888394 Dutch.
Safety and efficacy of nintedanib as second-line therapy for patients with differentiated or medullary thyroid cancer progressing after first-line therapy. A randomized phase II study of the EORTC Endocrine Task Force (protocol 1209-EnTF).
Leboulleux S, Kapiteijn E, Litière S, Schöffski P, Godbert Y, Rodien P, Jarzab B, Salvatore D, Zanetta S, Capdevila J, Bastholt L, De La Fouchardiere C, Lalami Y, Bardet S, Cornélis F, Dedecjus M, Links T, Sents W, Schlumberger M, Locati DL, Newbold K. Leboulleux S, et al. Front Endocrinol (Lausanne). 2024 Jun 27;15:1403687. doi: 10.3389/fendo.2024.1403687. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39015176 Free PMC article. Clinical Trial.
325 results